ARCH Venture Fund VIII L.P. 13D/13G Filings for Metacrine, Inc. (MTCR)

ARCH Venture Fund VIII L.P. 13D and 13G filings for Metacrine, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-02
5:04 pm
Purchase
2020-12-3113GMetacrine, Inc.
MTCR
ARCH Venture Fund VIII L.P.2,940,503
11.300%
2,940,503increase
(New Position)
Filing